# Einträge: 87
Vernon, S.D., Zheng, T., Do, H. et al.
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study
J GEN INTERN MED (2025)
> https://doi.org/10.1007/s11606-024-09290-9
Keywords: Post-COVID-19 ME/CFS; ME/CFS; SARS-CoV-2; RECOVER
Huang, D.; Xuan, W.; Li, Z.
Impact of COVID-19 on Ocular Surface Health: Infection Mechanisms, Immune Modulation, and Inflammatory Responses
Viruses 2025, 17, 68
> https://doi.org/10.3390/v17010068
Hunt J, Blease C
Re-visiting professional ethics in psychotherapy: reflections on the use of talking therapies as a supportive adjunct for myalgic encephalomyelitis/chronic fatigue syndrome and ‚medically unexplained symptoms‘
J Med Ethics 2024;0:1–9 – Epub ahead of print: 31.12.2024
> https://doi.org/10.1136/jme-2023-109627
Hoheisel, F.; Fleischer, K.M.; Rubarth K.; et al
Autoantibodies to Arginine-rich Sequences Mimicking Epstein-Barr Virus in Post-COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
medRxiv 2024.12.30.24319800
> https://doi.org/10.1101/2024.12.30.24319800
Preprint
Scheibenbogen, C.; Wirth, K.
Key Pathophysiological Role of Skeletal Muscle Disturbance in Post COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Accumulated Evidence
Journal of Cachexia, Sarcopenia and Muscle, 16: e13669
> https://doi.org/10.1002/jcsm.13669
Keywords: long COVID; mitochondrial damage; myalgic encephalomyelitis/chronic fatigue syndrome; post–COVID-19; skeletal muscle; vascular dysfunction
Zollner A, Meyer M, Jukic A, et al.
The Intestine in Acute and Long COVID: Pathophysiological Insights and Key Lessons
Yale J Biol Med. 2024 Dec 19;97(4):447-462
> https://doi.org/10.59249/PMIE8461
Keywords: Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), Long COVID, Post COVID, Gut microbiome, Gut-brain axis, Immune dysregulation, SARS-CoV-2 antigen persistence, Gastrointestinal symptoms, Neuropsychiatric symptoms, Chronic inflammation, Microvascular damage, Autonomic nervous system dysfunction, Dysbiosis, COVID-19 pathophysiology, Personalized medicine, Diagnostic biomarkers
Hohberger, B,; Ganslmayer, M.; Harrer, T.; et al.
Safety, tolerability and clinical effects of BC007 (Rovunaptabin) on fatigue and quality of life in patients with post-COVID syndrome (reCOVer): a prospective, exploratory, randomised, placebo-controlled, double-blind, crossover phase IIa clinical trial
medRxiv 2024.12.13.24318856
> https://doi.org/10.1101/2024.12.13.24318856
Preprint
Iu, D.S.; Maya, J.; Vu, L.T.; et al.
Transcriptional reprogramming primes CD8+ T cells toward exhaustion in Myalgic encephalomyelitis/chronic fatigue syndrome
Proc. Natl. Acad. Sci. U.S.A. 121 (50) e2415119121
> https://doi.org/10.1073/pnas.2415119121
Im Artikel wird eine aktuelle Studie vorgestellt, die sich mit den immunologischen Mechanismen von Long-COVID und möglichen Zusammenhängen mit ME/CFS beschäftigt. Die Forschungsergebnisse bieten neue Einblicke in die Krankheitsprozesse und könnten für die Entwicklung zukünftiger Behandlungsansätze von Bedeutung sein. [Zusammenfassung generiert mit KI]
Kubisiak, A., Dabrowska, A., Botwina, P. et al.
Remodeling of intracellular architecture during SARS-CoV-2 infection of human endothelium
Sci Rep 14, 29784 (2024)
> https://doi.org/10.1038/s41598-024-80351-z
Keywords: SARS-COV-2; COVID-19; Endothelial cells; Variants; Elasticity; AFM
Kovács, F., Posvai, T., Zsáry, E. et al.
Long COVID syndrome in children: neutrophilic granulocyte dysfunction and its correlation with disease severity
Pediatr Res (2024)
> https://doi.org/10.1038/s41390-024-03731-1